---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-253754"
form_type: "8-K"
ticker: "CALC"
cik: "0001534133"
company_name: "CalciMedica, Inc."
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:47:47.054422+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CalciMedica appoints Stephen Bardin as CFO; Dan Geffken resigns as interim CFO

## Summary
- Dan Geffken resigned as interim CFO effective after filing Q3 2024 10-Q.
- Stephen Bardin appointed CFO, principal financial and accounting officer; previously a consultant since April 2024.
- Bardin served as CFO of ATAI Life Sciences (2022-2024) and SVP Finance at BridgeBio (2022).
- Compensation: $380k base salary, $20k signing bonus, 100k stock option and 40k RSUs granted.
- Option vests 25% on Oct 1, 2025 then monthly; RSUs vest 25% on Oct 1, 2025 then quarterly.

## SEC filing metadata
- accession: 0001193125-24-253754
- form_type: 8-K
- ticker: CALC
- cik: 0001534133
- company_name: CalciMedica, Inc.
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534133/000119312524253754/0001193125-24-253754-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534133/000119312524253754/d862451d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-253754
- JSON: https://secwatch.observer/filing/0001193125-24-253754.json
- Plain text: https://secwatch.observer/filing/0001193125-24-253754.txt

## Key facts
- Executive change
  Dan Geffken resigned as interim Chief Financial Officer at CalciMedica, Inc..
  - Action: resigned
  - Role: interim Chief Financial Officer
  source text: Dan Geffken tendered his resignation as interim Chief Financial Officer, principal financial officer and principal accounting officer of CalciMedica, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312524253754/0001193125-24-253754-index.htm
- Executive change
  Stephen Bardin was appointed as Chief Financial Officer at CalciMedica, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: the Company’s board of directors (the “Board”) appointed Stephen Bardin as the Company’s Chief Financial Officer, as well as the Company’s principal financial officer and principal accounting officer effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312524253754/0001193125-24-253754-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.